Filed with ASX · · 4 pages · English
The funds will enhance Dorsavi's capabilities in capturing human movement data and advance its neuromorphic and RRAM development programs. The placement received strong demand from sophisticated investors, reflecting confidence in Dorsavi's growth potential across its connected verticals. The company aims to leverage its clinical-grade data for applications in robotics and autonomous systems, targeting various innovative projects.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
dorsaVi Limited ASX: DVL | ABN: 15 129 742 409 Level 50/108 St Georges Terrace, Perth WA 6000 dorsavi.com Page 1 ASX:DVL 6 October 2026 dorsaVi Raises A$3.0 Million for Humanoid Robotics Strategy and RRAM Chip Tape-Out Funding commitments received to expand...
Follow dorsaVi into a list and get an email when it puts out news.
Follow dorsaVi